Navigation Links
Migenix in Medical News

New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report

... Albuferon II-58 Intarcia Releases Study Results of Omega Interferon II-58 Nautilus Biotech Commences Phase I Study for Belerofon(R) II-58 migenix Announces Phase II Proof-of-Concept Study Results of Celgosivir II-59 Pharmasset Begins Multiple Dose-Escalating Study of R7128 II-59 Tran...

MIGENIX Reports Preliminary Celgosivir Viral Kinetics Study

...ER, and SAN DIEGO, Dec. 3 /PRNewswire-FirstCall/ - migenix Inc. (TSX: MGI, OTC: MGIFF), a clinical-stage deve...of sustained treatment response. About MIGENIX migenix is committed to advancing therapy, improving healt...e treatment of dermatological diseases (Phase II). migenix is headquartered in Vancouver, British Columbia, C...
Migenix in Medical Technology

Cutanea Announces Promising Phase II Results in Rosacea with Omiganan

...usive worldwide rights for dermatological uses to a novel, cationic, antimicrobial peptide, whose active component is omiganan pentahydrochloride from migenix Inc., a British Columbia Corporation located in Vancouver, BC, Canada (TSX: MGI; OTC: MGIFF). Omiganan is in development as a topical treatment for pa...

New Clinical Study Results Indicate Higher Early Virologic Response with Celgosivir Combination Therapy in HCV Non-Responders

...DIEGO, CA, April 11, 2007 /PRNewswire-FirstCall/ - migenix Inc. , a clinical-stage developer of drugs for inf...ng-Plough Corporation ("Schering") having informed migenix that approximately 50% of the original viral load ...sen, M.D., Vice President, Clinical Development of migenix stated, "the increase in EVR to 42% after retestin...

Migenix to Present Celgosivir Phase II Hepatitis C Results at Digestive Disease Week 2007

...versity of Manitoba and a lead investigator in the migenix Phase II study will make the presentation. The p...sen, M.D., Vice President, Clinical Development of migenix will participate in a DDW news conference highligh...s to improve efficacy in anti-HCV therapy. About migenix ...
Migenix in Biological Technology

Notice of MIGENIX General Meeting of Shareholders

VANCOUVER and SAN DIEGO, July 24 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases, advises that the directors of MIGENIX Inc. have called a general meeting of shareholders (the "Meeting") to be held at 2:00 p.m. (Vancouve...

MIGENIX Reports First Quarter Fiscal 2009 Financial Results

... VANCOUVER, Sept. 15 /PRNewswire-FirstCall/ - migenix Inc. (the "Company" or "MIGENIX") (TSX: MGI; OTC: ...or the three months ended July 31, 2008 ("Q1/09"), migenix incurred a loss of $2.6 million (Q1/08: $3.1 milli...of the convertible royalty participation units). migenix believes that its funds on hand at July 31, 2008 a...

Migenix averts proxy contest; reaches agreement with DJohnson holdings

... VANCOUVER, Aug. 11 /PRNewswire-FirstCall/ - migenix Inc. ("MIGENIX") announced today that it has reach...ed for October 31, 2008. As part of the agreement, migenix has reduced the size of its board of directors fro...NIX, commented: "We are pleased a solution between migenix and DJohnson has been reached. As a result of a de...

MIGENIX Fourth Quarter and Fiscal Year 2008 Financial Results Conference Call & Webcast Notification

...website at http://www.migenix.com for the next 90 days. About MIGENIX migenix is committed to advancing therapy, improving health, and enriching life by ...ns (preclinical) and the treatment of hepatitis B infections (preclinical). migenix is headquartered in Vancouver, British Columbia, Canada with US operations ...

MIGENIX Corporate Update and Requisition of Special Meeting

...VER and SAN DIEGO, July 8 /PRNewswire-FirstCall/ - migenix Inc. (TSX: MGI, OTC: MGIFF), a clinical-stage deve...ent and the board maintain their commitment to all migenix shareholders to create value based on our existing...Update"). Jim DeMesa, M.D., President and CEO of migenix stated, "Since announcing our strategic plan in 20...

Migenix Takes Operational Actions To Extend Cash Past Upcoming Key Milestones

...VER and SAN DIEGO, May 27 /PRNewswire-FirstCall/ - migenix Inc. (TSX: MGI, OTC: MGIFF), a clinical-stage deve..." below). Jim DeMesa, M.D., President and CEO of migenix stated, "We must preserve our cash during this ver...actions are expected to achieve both. All of us at migenix are committed to creating value for our shareholde...

MIGENIX Appoints Pieter Dorsman to Board of Directors

...R and SAN DIEGO, April 21 /PRNewswire-FirstCall/ - migenix Inc. (TSX: MGI, OTC: MGIFF), a clinical-stage deve...r ten years of service. David Scott, Chairman of migenix stated, "We owe a great deal to Mr. Mallet for his... company over the coming years." About MIGENIX migenix is committed to advancing therapy, improving healt...

MIGENIX Reports Third Quarter Fiscal Year 2008 Financial Results

...R and SAN DIEGO, March 13 /PRNewswire-FirstCall/ - migenix Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage deve...s programs. Jim DeMesa, M.D., President & CEO of migenix stated, "With the conclusion of our third fiscal q...09. Under the terms of the agreement with Cadence, migenix will receive up to US$27 million in development an...

MIGENIX Third Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification

...R and SAN DIEGO, March 11 /PRNewswire-FirstCall/ - migenix Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage deve...genix.com for the next 90 days. About MIGENIX migenix is committed to advancing therapy, improving healt...treatment of hepatitis B infections (preclinical). migenix is headquartered in Vancouver, British Columbia, C...

MIGENIX releases CEO message #22

...o available on SEDAR and EDGAR). About MIGENIX migenix is committed to advancing therapy, improving healt...e treatment of dermatological diseases (Phase II). migenix is headquartered in Vancouver, British Columbia, C...or accuracy of this release. CONTACT: Art Ayres, migenix Inc., Tel: (604) 221-9666 Ext. 233, aayres@migenix...
Other Tags
(Date:9/23/2014)... better screening strategies can lower the rate of false-positive ... on women. The many misperceptions about breast cancer screening ... and the need for new approaches and better education ... supplement to Journal of Women,s Health , a ... supplement is available free on the Journal of ...
(Date:9/23/2014)... National Institutes of Health has awarded $10.1 million in ... to explore the effects of sex in preclinical and ... females and males, and is a catalyst for considering ... overreliance on male subjects in preclinical research can obscure ... human studies. This progressive approach will result in greater ...
(Date:9/23/2014)... BLOOMINGTON, Ind. -- Contrary to what is often assumed ... a new study from The Kinsey Institute has found ... and are sexually active as often as singles without ... older children. , The study, "Dating and Sexual Behavior ... States," was published online in the Journal of ...
(Date:9/23/2014)... 2014 PM360, a leading health-marketing industry ... industry with their annual Trailblazer Awards on Thursday, September ... at Gotham Hall in New York City, are given ... talent and brands. , “This industry ... Stashower, CEO and Publisher of PM360. “We are happy ...
(Date:9/23/2014)... 2014 The University of Maryland Medical System ... Court to pay $3 million for negligence during the delivery ... anterior arm [shoulder dystocia occurs after the delivery of the ... mother’s pelvic bone]. , On September 5, ... Uriah Evans, et. al. v. University of Maryland Medical Systems ...
Breaking Medicine News(10 mins):Health News:Opportunities to reduce patient burden associated with breast cancer screening 2Health News:New supplemental awards apply sex and gender lens to NIH-funded research 2Health News:New supplemental awards apply sex and gender lens to NIH-funded research 3Health News:Kinsey study of single parents' dating, sexual activity contradicts assumptions 2Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 2Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 3Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 4Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 5Health News:PM360 Magazine Announces Winners of 2014 Trailblazer Awards 6Health News:Toddler Awarded $3 Million in a Shoulder Dystocia Case Against University of Maryland Medical System with Help from Attorneys at Gilman & Bedigian LLC 2Health News:Toddler Awarded $3 Million in a Shoulder Dystocia Case Against University of Maryland Medical System with Help from Attorneys at Gilman & Bedigian LLC 3
(Date:9/22/2014)... Yale University researchers are studying a potential new ... respiratory disease in which scars develop in the lungs ... microRNA mimic, miR-29, which is delivered to lung tissue ... fibrosis, it reversed fibrosis after several days. , ... EMBO Molecular Medicine . , "The mimic, when ...
(Date:9/22/2014)... New Rochelle, NY, September 22, 2014Cassava, also known as ... high yields in areas of Africa, Asia, and Latin ... With the availability of novel enzymes and processes designed ... then be used to produce sweeteners such as glucose, ... alternative to corn, as described in a Review article ...
(Date:9/22/2014)... manufacture their own "antifreeze" proteins to survive in ... side effect, researchers report: The protein-bound ice crystals ... when temperatures warm. , The finding is ... Academy of Sciences . , "We discovered what ... evolution of antifreeze proteins in Antarctic notothenioid fishes," ...
Breaking Biology News(10 mins):Reversing the effects of pulmonary fibrosis 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 3
Other Contents